3,0
10. Juli 2009
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Roche is relatively stable for the next few years (no major patent expiration looming), so there is some degree of job security.
Kontras
There are so many changes going on that are creating an uncertain environment at Palo Alto as well as Genetech.